Table of Content - Europe Platelet Rich Plasma Market

Platelet-rich plasma consists of two elements: plasma, or the liquid portion of blood, and platelets, a type of blood cell that plays an important role in healing throughout the body. Platelets are well-known for their clotting abilities, but they also contain growth factors that can trigger cell reproduction and stimulate tissue regeneration or healing in the treated area. Platelet-rich plasma is simply blood that contains more platelets than normal. Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. PRP is injected directly at the site of inflamed tissue releasing growth factor which stimulates and increases number of reparative cell in patient body. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. PRP is used for treatment of injured tendons, ligaments, muscles and joints Increasing prevalence of musculoskeletal injuries along with increasing prevalence of knee osteoarthritis is expected to boost growth of Europe platelet-rich plasma market over the forecast period.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launch by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, on February 14 2023, Royal Biologics, an orthobiologics & life science company, announced the commercial launch of BIOINCYTE PRFM, a next-generation Platelet Rich Plasma (PRP) system, which converts traditional PRP to Platelet Rich Fibrin Matrix (PRFM) formulations and eliminates extensive contamination of red blood cells & white blood cells during the formulation of PRP.

Key features of the study:

This report provides in-depth analysis of the Europe platelet rich plasma, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the europe platelet rich plasma based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Vivostat A/S, Estar Medical, CosmoFrance Inc., Kelly Harris Aesthetics, Arthrex, Inc., Terumo Corporation, T-Biotechnology Ltd. St., EmCyte Corporation, Johnson & Johnson Private Limited, Zimmer Biomet, PRP Concepts, ADVACARE PHARMA, Isto Biologics, Arthrex, Inc., Stryker, GLOFINN, Medira Ltd, Regen Lab SA, Estar Technologies Ltd.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe platelet rich plasma

Detailed Segmentation:

Europe Platelet Rich Plasma Market, By PRP Type:
- Pure-PRP
- Leukocyte-Rich PRP
- Pure Platelet Rich Fibrin
- Others
Europe Platelet Rich Plasma Market, By Origin:
- Autologous
- Allogeneic/Homologues
Europe Platelet Rich Plasma Market, By Application:
- Orthopaedics
- Cosmetic Surgery and Dermatology
- Neurosurgery
- Cardiothoracic Surgery
- General Surgery
- Urology
- Others
Europe Infection Surveillance Market, By Country:
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Middle East
Company Profiles
- Vivostat A/S*
- Estar Medical
- CosmoFrance Inc.
- Kelly Harris Aesthetics
- Arthrex, Inc.
- Terumo Corporation
- T-Biotechnology Ltd. St.
- EmCyte Corporation
- Johnson & Johnson Private Limited
- Zimmer Biomet
- PRP Concepts
- ADVACARE PHARMA
- Isto Biologics
- Arthrex, Inc.
- Stryker
- GLOFINN
- Medira Ltd
- Regen Lab SA
- Estar Technologies Ltd.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By PRP Type
  - Market Snapshot, By Origin
  - Market Snapshot, By Application
  - Market Snapshot, By Country
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Attractiveness Analysis
  - Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- PORTER’s Analysis
- Pricing Analysis (2021)
Europe Platelet rich Plasma Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Europe Platelet rich Plasma Market, By PRP Type, 2018 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Pure-PRP
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Leukocyte-Rich PRP
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Pure Platelet Rich Fibrin
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Europe Platelet rich Plasma Market, By Origin, 2018 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Autologous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Allogeneic/Homologues
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Europe Platelet rich Plasma Market, By Application, 2018 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Orthopaedics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Cosmetic Surgery and Dermatology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Neurosurgery
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Cardiothoracic Surgery
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- General Surgery
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Urology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
Europe Platelet rich Plasma Market, By Country, 2018 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, By Country, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2030
  - Regional Trends
- U.K.
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Germany
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- France
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Italy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Spain
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Russia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Rest of Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Competitive Landscape
- Vivostat A/S
  - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Estar Medical
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - CosmoFrance Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Kelly Harris Aesthetics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Arthrex, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Terumo Corporation
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - T-Biotechnology Ltd. St.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - EmCyte Corporation
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Johnson & Johnson Private Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Zimmer Biomet
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - PRP Concepts
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - ADVACARE PHARMA
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Isto Biologics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Arthrex, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Stryker
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
  - GLOFINN
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
  - Medira Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
  - Regen Lab SA
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
  - Estar Technologies Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
Section
- Research Methodology
- About Us

*Browse 16 market data tables and 10 figures on “Europe Platelet Rich Plasma Market”- Europe forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount